Aravax Establishes Pharmaceutical Development base on the Oxford Science Park with a Focus on Developing Manufacturing Capabilities in the UK
MELBOURNE, Australia and OXFORD, United Kingdom, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Aravax, a clinical-stage biotechnology company developing ...
Business Insider6h
Taysha Gene Therapies Advances in Rett Syndrome Trials
Taysha Gene Therapies, Inc. is a clinical-stage biotechnology company focusing on adeno-associated ... Taysha is in advanced discussions with the FDA regarding trial design and endpoints, aiming for ...
News Medical18h
The ultimate guide to navigating CMC in drug development
The panel featured industry leaders from the pharmaceutical and biotech sectors, who discussed these challenges and provided ...
TORK US on MSN18h
This is how Audi was born: the origin of its iconic four rings
This is the origin of the Audi logo, a symbol full of globalization, a design available to any mortal, easy to reproduce by ...
BioPharma Dive21h
BioNTech to buy Biotheus, gaining control of cancer bispecific
Biotheus’ antibody drug targets PD-L1 and VEGF, a design that’s high on drugmakers’ radars after the success of Summit ...